The study also found that proteasome inhibitors lead to increases in Aβ and tau levels in pre-pathological 3xTg-AD mice, thus pointing to proteasomal stress as a contributor to the multi-proteinopathy of AD. Here, MAPT is linked to Alzheimer disease.